期刊文献+

药物流产后加服米非司酮预防蜕膜残留的剂量比较 被引量:1

Comparison of the Dose of Mifepristone in the Prevention of the Residual Drug Abortion After Drug Abortion
下载PDF
导出
摘要 目的药物流产后加服不同剂量的米非司酮对预防蜕膜残留的临床效果。方法选取2016年1月至10月于佛山三水区人民医院行药物流产的1200例妇女作为研究对象,随机分成4组,即对照组、A组、B组、C组各300例。A组妇女药流后第1 d早晚各加服米非司酮25 mg,共50 mg;B组妇女药流后第1~3 d早晚各加服米非司酮25 mg,共150 mg;C组妇女于药流后第1~5 d早晚各加服米非司酮25 mg,共250 mg,对照组妇女药流后不加服米非司酮。观察4组妇女药流后组织蜕膜残留情况。结果 A、B、C组与对照组相比,均具有统计学差异(P<0.05);与对照组相比,A、B、C组妇女组织蜕膜残留情况明显更好(P<0.05);且B组妇女组织蜕膜残留情况优于A、C两组(P<0.05)。结论用米非司酮加米索前列醇对妇女成功实施药物流产后,连续3 d加服米非司酮(50 mg/d)能有效预防蜕膜残留,在一定程度上减少药物流产后蜕膜残留的几率,值得临床推广。 Objective To prevent the effect of different doses of mifepristone on the prevention of residual drug abortion after drug abortion.Methods 1200 women with drug abortion in Sanshui District People’s Hospital of Foshan from January 2016 to October were randomly divided into 4 groups:control group,A group,B group and C group,300 cases in each group.Group A women in after drug abortion 1 day sooner or later each plus mifepristone 25 mg,a total of 50mg;Group B women in after drug abortion 1-3days sooner or later each plus mifepristone 25 mg,a total of 150 mg;Group C women in after medical abortion 1-5 days sooner or later each plus service mifepristone 25 mg,a total of 250 mg,control group drug abortion without clothing and our ketone.To observe the decidua of 4 groups of women after drug residues.Results Compared with the control group,the B,A and C groups were significantly better(P〈0.05),and the residue of the B group was better than that of A and C two groups(P〈0.05).Conclusion The women in drug abortion with mifepristone plus misoprostol after continuous 3D mifepristone(50mg/d)can effectively prevent the risk of decidual residue,to a certain extent,reduce the rudimental decidua after medical abortion,worthy of promotion.
出处 《哈尔滨医药》 2017年第2期105-106,共2页 Harbin Medical Journal
基金 佛山市科学技术局2015年课题<加服不同剂量米非司酮预防药物流产后蜕膜残留差异性分析>(2015AB001345)
关键词 药物流产 米非司酮 预防 蜕膜残留 Drug abortion Mifepristone Prevention Residual
  • 相关文献

参考文献7

二级参考文献56

  • 1隋明凤.药物流产后阴道出血及宫腔刮出物的病理变化[J].中国初级卫生保健,2005,19(7):90-90. 被引量:5
  • 2刘伯宁,孙剑英,陶雯琪,蔡敏芳,杨美娟.米非司酮终止早孕流产物的病理观察[J].中华妇产科杂志,1995,30(1):7-9. 被引量:104
  • 3孔建平.药物流产后阴道出血160例临床病理分析[J].现代中西医结合杂志,2006,15(14):1948-1948. 被引量:4
  • 4邱晓燕,酆豫增,李大金,李超荆.米非司酮抗早孕后出血量与宫腔组织学观察[J].生殖与避孕,1997,17(2):82-85. 被引量:105
  • 5刘爱华.中药治疗产后胎盘胎膜残留临床体会.中国临床研究,2009,3(6):82-82.
  • 6Wang CY, Mayo MW, Korneluk RG, et al. NF-kappaB antiapoptosis., induction of TRAFI and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation[J]. Science, 1998, 281 (5383) z 1680-1683.
  • 7Hirchenhain J, Huse I, Hess A, et al. Differential expression of an- giopoietins 1 and 2 and their receptor Tie-2 in human endometrium [J]. Mol Hum Report,2003,9(ll) z663-669.
  • 8Blumenthal RD, Taylor AP, Goldman L, et al. Abnormal expres- sion of the angiopoietins and Tie receptors in menorrhagic en- dometrium[J]. Fertil Steril,2002,78(6) 1294-300.
  • 9Shi WL,Wang JD, Fu Y,et al. Estrogen and progesterone receptors in human decidua after RU486 treatment[J]. Fertil Steril, 1993,60 ( 1 ) : 69 - 74.
  • 10BischofP, Sizonenko MT, Herrmann WL, et al. Trophoblastic and decidual response to RU486:effects on human chorionic gonadotrophin, human placental lactogen, prolactin and pregnancy-associated plasma protein-A production in vitro [J]. Hum Reprod, 1986, 1(1):3-6.

共引文献100

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部